PURPOSE: Irritable bowel syndrome is generally diagnosed according to the symptoms of the patient, and gluten enteropathy can also be presented with similar symptoms (diarrhea and/or constipation) of irritable bowel syndrome. Aimed to assess the association and the frequency of gluten enteropathy in a group of Turkish patients diagnosed as irritable bowel syndrome. RESULTS: Found anti-gliadin IgA positivity only in four patients among patients with irritable bowel syndrome. However, none of these four patients had anti-endomycium positivity or any histopathological findings specific for gluten enteropathy. All these four patients had normal histology in their small bowel biopsies. CONCLUSION: Irritable bowel syndrome is a common problem in the population, but gluten enteropathy is not associated with the vast majority of subjects with irritable bowel syndrome as expected. The need for screening gluten enteropathy among these patients is still unclear, and screening with serology only without small bowel biopsy may lead to false positive results.
PURPOSE:Irritable bowel syndrome is generally diagnosed according to the symptoms of the patient, and gluten enteropathy can also be presented with similar symptoms (diarrhea and/or constipation) of irritable bowel syndrome. Aimed to assess the association and the frequency of gluten enteropathy in a group of Turkish patients diagnosed as irritable bowel syndrome. RESULTS: Found anti-gliadin IgA positivity only in four patients among patients with irritable bowel syndrome. However, none of these four patients had anti-endomycium positivity or any histopathological findings specific for gluten enteropathy. All these four patients had normal histology in their small bowel biopsies. CONCLUSION:Irritable bowel syndrome is a common problem in the population, but gluten enteropathy is not associated with the vast majority of subjects with irritable bowel syndrome as expected. The need for screening gluten enteropathy among these patients is still unclear, and screening with serology only without small bowel biopsy may lead to false positive results.
Authors: Lawrence J Brandt; David Bjorkman; M Brian Fennerty; G Richard Locke; Kevin Olden; Walter Peterson; Eamonn Quigley; Philip Schoenfeld; Marvin Schuster; Nicholas Talley Journal: Am J Gastroenterol Date: 2002-11 Impact factor: 10.864
Authors: Clare O'Leary; Peter Wieneke; Sarah Buckley; Paud O'Regan; Comeilius C Cronin; Eamonn M M Quigley; Fergus Shanahan Journal: Am J Gastroenterol Date: 2002-06 Impact factor: 10.864
Authors: G Richard Locke; Joseph A Murray; Alan R Zinsmeister; L Joseph Melton; Nicholas J Talley Journal: Mayo Clin Proc Date: 2004-04 Impact factor: 7.616
Authors: David S Sanders; Dina Patel; Timothy J Stephenson; Anthony Milford Ward; Eugene V McCloskey; Marios Hadjivassiliou; Alan J Lobo Journal: Eur J Gastroenterol Hepatol Date: 2003-04 Impact factor: 2.566
Authors: Brooks D Cash; Joel H Rubenstein; Patrick E Young; Andrew Gentry; Borko Nojkov; Dong Lee; A Hirsohi Andrews; Richard Dobhan; William D Chey Journal: Gastroenterology Date: 2011-07-14 Impact factor: 22.682
Authors: Ann E Almazar; Nicholas J Talley; Joseph J Larson; Elizabeth J Atkinson; Joseph A Murray; Yuri A Saito Journal: Eur J Gastroenterol Hepatol Date: 2018-02 Impact factor: 2.566